Form 4: Carlsmed COO Sells Shares
Insider Transaction (Form 4)
Jeffrey Bertolini, Chief Operating Officer of Carlsmed, Inc., sold 243 shares of common stock on September 30, 2026 for $13.99 per share.
Summary
- Option exercise/conversion: acquired 243 Common Stock at $2.23 ($542) on September 30, 2026; holds 22,732 after (Direct).
- Open-market sale: disposed of 243 Common Stock at $13.99 ($3,400) on September 30, 2026; holds 22,489 after (Direct).
- Option exercise/conversion: disposed of 243 Stock Option (Right to Buy) on September 30, 2026; holds 5,825 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $3,400 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Jeffrey Bertolini — Officer (Chief Operating Officer)
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-30 | Option exercise/conversion | Common Stock | 243 | $2 | $542 | 22,732 |
| 2026-09-30 | Open-market sale | Common Stock | 243 | $14 | $3.4K | 22,489 |
| 2026-09-30 | Option exercise/conversion | Stock Option (Right to Buy) | 243 | — | — | 5,825 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-30 | Option exercise/conversion (243 shares) |
| 2026-09-30 | Open-market sale (243 shares) |
| 2026-09-30 | Option exercise/conversion (243 shares) |
Keywords
insider transaction, Form 4, CARL, CARLSMED, INC., bearish, Jeffrey Bertolini
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.